26.3 C
New Delhi
Thursday, October 14, 2021
HomeWorld NewsBharat Biotech terminates Covaxin deal with Brazil’s Precisa

Bharat Biotech terminates Covaxin deal with Brazil’s Precisa


Bharat Biotech terminated the MOU for the sale of its COVID-19 vaccine Covaxin Brazilian Precisa Medicamentos, an Indian company reported on Friday without disclosing the reason.

Bharat said in a statement that it will continue to work with Brazilian health regulator Anvisa to obtain all necessary approvals for Covaxin to be used in the country.

In Brazil, there have been allegations of irregularities in the government’s efforts to procure 20 million doses of vaccine using Precisa as an intermediary.



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments